Brachyury
Introduction
During vertebrate development the embryonic body grows in an anterior to posterior direction. Elongation of the anteroposterior (A-P) axis depends on the progressive addition of new tissue at the posterior end of the embryo, which is generated by a transient structure called the primitive streak (ps). In mouse embryos, the ps forms at embryonic day (E) 6.5 and is replaced by the tail bud at mid-somite stages (E9.25-E9.5, P22 somites) (for review, see Beddington, 1983) .
Cells located in the ps differentiate into mesendodermal tissue, marked by the expression of genes such as Brachyury (T) (Herrmann, 1991) . These cells undergo an epithelial-tomesenchymal transition (EMT), allowing them to become motile, migrate away from the ps, and intercalate between the definitive endoderm and ectoderm (reviewed in Baum et al., 2008) . Epithelial epiblast cells provide a constant source of mesodermal cells. At E7.5 a complete layer of mesoderm has formed between the ectoderm and endoderm, but EMT continues until axis elongation ceases between E12.5 and E13.5 (Cunningham et al., 2011) . EMT has been shown to be a central process during various stages of embryonic development including gastrulation, neural crest formation, and heart morphogenesis (Lim and Thiery, 2012) . Moreover, the essential role of EMT in tumor metastasis has been well studied. EMT is a multistep process that comprises the degradation of cell-cell contact proteins (e.g., E-cadherin), the breakdown of the basement membrane, and the regulation of cytoskeletal reorganization (Nakaya and Sheng, 2008; Levayer and Lecuit, 2008) . As a consequence, mesenchymal cells lose contact with their neighboring cells, which is a prerequisite for migratory capacity, and they adopt a more extended and elongated shape.
The molecular basis that underlies EMT during mouse gastrulation is only partly understood. Genetic studies in mice have demonstrated that FGF induces downregulation of Ecadherin in ps cells, both at the transcriptional and post-transcriptional levels (Ciruna and Rossant, 2001; Zohn et al., 2006) , thereby inducing the delamination of cells from the epithelium. In addition to FGF, several other extracellular signaling molecules contribute to EMT in generating mesodermal cells, including members of the Wnt and TGFb families (Ben-Haim et al., 2006; Kemler et al., 2004) . It has also been shown that Wnt signaling is required to specify a pool of multipotent stem cells in the caudal region of vertebrate embryos (Martin and Kimelman, 2012) , and that these axial stem cells are required for vertebrate axis extension (for review see Wilson et al., 2009 ). The molecular characterization of these stem cells is pending, but it is already established that Sox genes are involved in their function (Yoshida et al., 2014) .
The gene encoding the transcription factor Serum Response Factor (SRF) is expressed in the ps and newly formed mesoderm in several vertebrates at early stages of gastrulation (Barron et al., 2005; Croissant et al., 1996; Mohun et al., 1991) , but its role during mesoderm development and axis elongation has not received careful investigation. SRF is a homodimeric MADS-box-containing transcription factor, which binds a 10 bp sequence known as the CArG box (Norman et al., 1988; Shore and Sharrocks, 1995) . More than 170 bona fide SRF target genes have been identified (reviewed in Miano, 2008) . These mainly comprise genes involved in muscle cell differentiation, as well as the regulation of cell growth, cell survival, and cell motility (Johansen and Prywes, 1995; Miano, 2003) .
Srf À/À mouse embryos show severe gastrulation defects, including lack of the ps, and die at mid-gestation (Arsenian et al., 1998) . Srf mutants lack all mesodermal tissue and begin to be resorbed from stage E8.5 onwards. While these data identified SRF as a regulator of mesoderm induction, they did not provide insight into the role that SRF plays once the ps has formed. Thus, in order to study the role of SRF during axis elongation, we conditionally deleted Srf in murine ps cells using Cre recombinase driven by the Brachyury (T) promoter region responsible for T expression in the ps (T(s)::Cre) (Feller et al., 2008) . The resulting mutant embryos displayed, amongst other defects, severe axis truncation -indicating that SRF is essential for axis elongation. We present both molecular and functional data to demonstrate that SRF is required for mesodermal cell migration during axis elongation. This identifies SRF as a main player in the EMT process during gastrulation and the subsequent mesodermal cell movements that are essential for axis elongation.
Results

Conditional deletion of Srf in Brachyury-expressing cells causes an arrest of axis elongation
In order to investigate the role of SRF during trunk development, we first analyzed its expression pattern in midgestational embryos. Whole mount in situ hybridization of E9.5 mouse embryos showed domains of increased Srf expression in the forebrain, the branchial arches, the intermediate mesoderm and in the paraxial mesoderm and caudal end (Fig. 1A) . Expression of Srf in nascent mesodermal tissue (such as the paraxial mesoderm) suggested a possible role in mesoderm development during axis elongation. To analyze the function of SRF in nascent mesoderm we generated mouse embryos lacking Srf in that tissue using the Cre/loxP system. Brachyury (T) is one of the earliest markers of mesoderm during development (Herrmann, 1991) , thus, we crossed the Srf flex1/flex1 mouse line carrying a loxP flanked exon one of Srf (Wiebel et al., 2002) with the T(s)::Cre (C57Bl/6J Tg(T-cre)1Gos ) line expressing Cre recombinase under control of the T streak promoter of T, comprised of the 600 bp upstream of the ATG codon (Feller et al., 2008) . This results in a reduction of Srf in anterior mesoderm of E8.5 embryos and a complete loss Srf expression in posterior mesodermal tissue (Fig. 2B ). The morphology of Srf flex1/flex1
; T(s)::Cre embryos was indistinguishable from wild type embryos until E8.5, but at E8.75 embryos showed malformations of the heart, the allantois, and had an overall smaller appearance ( Fig. 1C and D) . At E9.5, axis elongation in the mutants had been fully arrested, demonstrating an essential function for SRF in this process. At E10.5 no viable Srf flex1/flex1 ; T(s)::Cre embryos were observed. The role of SRF in heart development has already been described (Parlakian et al., 2004) , and abnormalities of the heart and allantois, resulting in defective nutrient and gas exchange, are the likely cause of death in the current model. In addition, this phenotype is in full agreement with previously observed impairment of mesoderm formation upon constitutive Srf deletion (Arsenian et al., 1998) .
2.2.
Mesenchymal character is not impaired in cells of the Srf flex1/flex1 ; T(s)::Cre embryo caudal end
The arrest of axis elongation observed here could be caused by the loss of mesoderm cells, therefore differing from Wnt3a or Brachyury mutant embryos where mesoderm induction and formation is impaired (Takada et al., 1994; Wilkinson et al., 1990) . In order to investigate this possibility we tested for the presence of BRACHYURY-positive cells in Srf mutant embryos by immunohistochemistry. Srf mutants have a significant number of BRACHYURY positive cells, indicating that mesoderm is indeed formed upon loss of SRF in cells progressing through the ps ( Fig. 2A ). An early hallmark of mesoderm formation is the initiation of EMT in the ps accompanied by loss of the cell surface marker E-cadherin. In Srf mutants EMT seems to be initiated, as E-cadherin is present in the epithelium surrounding the mesoderm, but not in the mesodermal cells of the caudal end ( Fig. 2A) . In addition, the mesenchymal marker Vimentin could be detected in the early mesoderm ( Fig. 2A) , further demonstrating that these cell have undergone EMT.
SRF was previously shown to promote cell survival in embryos by inhibiting apoptosis . We quantitatively assessed the number of apoptotic cells by counting Annexin V positive cells that were not necrotic (PI positive) in heads and caudal ends from single SRF mutants or control embryos by flow cytometry. In heads and caudal ends from E8.75 (TS13/14) control embryos we could detect 10.4% ± 1.8% and 10.5% ± 1.7% apoptotic cells, respectively ( Fig. 2C and D) . In SRF mutants the number of apoptotic cells in heads and caudal ends increased to 34.5% ± 1.0% and 23.7% ± 1.5%, respectively ( Fig. 2C and D) . We also measured the number of mitotic cells by staining for histone 3 serine 10 phosphorylation (H3S10P) and were not able to detect any changes ( Fig. 2E and F) . The increase in the number of apoptotic cells might explain the overall smaller appearance of the SRF mutant embryos, but is not sufficient to explain the axis truncation defect.
2.3.
RNA expression and ChIP data identified 25 direct SRF target genes during axis elongation
To elucidate the molecular mechanism behind the observed axis truncation phenotype, we dissected posterior ends composed of late ps and unsegmented, nascent mesoderm from Srf flex1/flex1 ; T(s)::Cre embryos and their heterozygous littermates. We examined gene expression at three distinct stages: (i) before malformations in the mutants became apparent (E8.5; 3-9 somites), (ii) when heart and allantoic malformations were visible, but before axis truncation was apparent (E8.75; 11-13 somites), and (iii) when axis elongation arrested (E9.0; 14-16 somites). As expected, Srf was downregulated at all three stages (Fig. 3) , demonstrating that Srf is effectively inactivated in caudal mesoderm by T(s)::Cre activity. Coincident with the observed increasing severity of the mutant phenotype, the total number of dysregulated genes increased from 10 genes at E8.5 to 139 genes at E8.75 and 439 genes at E9.0 (fold change P log 2 0.4 , p 6 0.05; n = 4) ( Table 1) .
To distinguish between direct and indirect targets of SRF during the process of axis extension, we used a genome-wide approach to search for genomic regions bound by SRF, via chromatin immunoprecipitation (ChIP). Chromatin was derived from P19 mouse embryonal carcinoma cells engineered to stably overexpress Srf. P19 cells are pluripotent and thus able to differentiate into derivatives of all three germ layers (McBurney, 1993) . They are reminiscent of epiblast cells from the early post-implantation blastocyst, and are often used to study events occurring during gastrulation (van der Heyden and Defize, 2003; Yeom et al., 1996) .
ChIP-seq analysis identified SRF-bound genomic regions throughout the genome. Previous work demonstrated that the vast majority of SRF binding sites reside within 4000 bp from the transcriptional start site (TSS) of a regulated gene Sun et al., 2006) , hence, we restricted our analysis to these genomic distances. Among the over 19,100 genes represented on the microarray we identified 658 genes (p-value 6 1 · 10 À5 ) containing one or more SRF peaks within 4000 bp of the TSS. Among these 658 genes, only 18 genes were differentially expressed between Srf flex1/flex1 ; T(s)::Cre embryos and heterozygous control embryos at all stages examined. Of those 18 genes, 12 (including Srf) have previously been described as SRF target genes, and six are novel putative Srf targets (Fig. 3) . In addition, we identified seven genes which showed differential expression in the microarray analysis, and have previously been shown to be bound by SRF in other cell types, but were not found to be bound by SRF in P19 cells. Taken together, we identified 25 genes that are bound by SRF and are dysregulated in the caudal ends of Srf flex1/flex1 ; T(s)::Cre embryos. Of these 25 direct SRF target genes we found 19 to be downregulated in the absence of Srf, whereas only six were found to be upregulated. This is consistent with previous reports suggesting that SRF mainly acts as a transcriptional activator (Schlesinger et al., 2011) . We validated the microarray data using qRT-PCR analysis on a subset of the SRF targets acting during axis elongation (Fig. 4) . The qRT-PCR data confirmed the microarray data, suggesting that all 25 genes identified in this work are dependent on Srf during the process of axis elongation.
While the overall number of genes directly regulated by SRF increased over the three stages analyzed (E8.5 = 6, E8.75 = 13 and E9.0 = 19) their percentage with respect to the total number of dysregulated genes decreased (E8.5 = 60%, E8.75 = 9.4% and E9.0 = 4.3%) ( Table 1) . It is likely that the increase in dysregulated genes is due to altered tissue composition of later stage Srf-deficient embryos, rather than reflecting an increase in the number of SRF target genes at later stages. Hence, the SRF targets found here are those most likely to be causal for the axis elongation defect observed in Srf-deficient embryos.
SRF controls cell migration during axis elongation
In order to elucidate the primary function of the 25 direct SRF targets identified in the process of axis extension, we performed Gene Ontology analysis (IngenuityÒ Pathway Analysis Tool) ( Table 2 ). The majority of these SRF target genes are found to be associated with cellular movement and cell morphology. Other functions identified were cellular assembly and organization, and cellular function and maintenance. Previous work in other systems showed that Srf is able to regulate cell motility and related functions (reviewed in Olson and Nordheim, 2010) . Hence, the primary role of SRF in the process of axis elongation seems to be controlling genes involved in cell morphology and cellular movement.
To examine impaired cell morphology and migration in Srf flex1/flex1 ; T(s)::Cre embryonic caudal ends, we analyzed caudal explants in an ex vivo system. Cell adhesion and migration of newly formed mesodermal cells emerging from the ps requires the extracellular matrix protein Fibronectin (George et al., 1997 (George et al., , 1993 Georges-Labouesse et al., 1996) and SRF-deficient embryonic stem cells are capable of attaching to Fibronectin-coated surfaces (Schratt et al., 2002) . Using this knowledge we performed explant culture assays on Fibronectin-coated dishes to determine the migratory potential of SRF-deficient mesoderm (Fig. 5A ). Caudal explants from both mutant and control embryos attached within one hour and cells began to migrate away from the explant. After 48 h of culture we measured the maximal distance between the explant and the edge of the migrating cells and observed a significant difference between SRF-deficient and control embryos (Fig. 5B) . The maximum distance observed was 604 lm ± 71 lm in mutant and 955 lm ± 59 lm in control explants (n = 5) (student's t-test: p = 2.9 · 10 À5 ). Explants migrate away after 5 h (300 min), while the cells from SRF deficient explants remain in close proximity to the explant tissue (Movie S1). As was seen in whole embryos, the number of apoptotic cells was increased in mesenchymal cells around the explants from the SRF mutants, while the number of mitotic cells did not change (Fig. 5C and D) . However, the majority of cells that do not undergo apoptosis remain in close proximity to the explant, exhibiting a reduced migration capability (Movie S1). From these experiments we concluded that SRF is required in vivo to control the cellular capacity for migration during axis elongation.
2.5.
The formation of stress fibers and focal adhesions is impaired in Srf-deficient embryo explants
In addition to impaired migration, we also observed that caudal cells derived from SRF-deficient embryo explants displayed differences in cell morphology as compared to control embryos. While most of the cells from control samples were long and spindle-shaped, typical hallmarks of motile mesenchymal cells, the cells from SRF-deficient caudal ends appeared small and rounded (Fig. 6A) . Several of the genes that we identified to be regulated by SRF in embryonic caudal ends encode actin monomers (Actb, Acta2), proteins involved in cytoskeletal actin organization (Tpm1, Tpm3, Tpm4, Wdr1, Pdlim7, Cnn2, Dstn, Anxa2, Fscn1) or in the formation of focal adhesions (Zyx, Vcl, Fhl2, Crk). We reasoned that the altered cell morphology observed in SRF-deficient explants might be due to defective formation of actin stress fibers and focal adhesions. To examine this possibility we stained control and mutant explants with FITC conjugated Phalloidin, to visualize F-actin fibers. The staining revealed reduced F-actin level in cells originating from SRF-deficient caudal ends as compared to controls (Fig. 6B ), in agreement with the observed decrease in expression of genes encoding actin (Table 2) . Furthermore, we noted a drastic difference in the structure of the cytoskeleton. While cells from control samples displayed stress fibers which traversed the entire cell body, these structures were significantly reduced in cells from SRF-deficient explants (Fig. 6B) . Immunofluorescent staining using an antibody against the focal adhesion protein Vinculin further showed impaired focal adhesion formation in SRFdeficient cells (Fig. 6C) . These cells displayed a mesenchymal character, as they were positive for Vimentin and no membrane associated E-cadherin was detected (Fig. 6C ). Since stress fibers and focal adhesions are essential cytoskeletal elements for migratory cells, their absence provides a molecular explanation for the observed impairment of cell migration in SRF-deficient embryo explants.
Discussion
SRF has previously been shown to be essential for neuronal migration in the mouse forebrain (Alberti et al., 2005) , as well as for spreading, adhesion, and migration of murine ES cells (Schratt et al., 2002) . In both of these prior studies downregulation of genes encoding either actin monomers (Actb) or proteins required for focal adhesion formation (Zyx, Vcl) caused impaired cell motility in Srf mutants associated with defective formation of actin stress fibers and focal adhesion plaques. Here we show that SRF is also essential for proper migration of nascent mesoderm formed at the ps of midgestation mouse embryos. We provide evidence that SRF is required for reorganization of the actin cytoskeleton in nascent mesoderm, and identify it as a crucial factor for A-P axis elongation.
In searching for direct SRF target genes acting in axis development on a genome-wide level, we identified several novel SRF targets, along with a number of previously described targets (Fig. 3) . Of note, v-crk sarcoma virus CT10 oncogene homolog (avian) (Crk1) and Fascin homolog 1 actin bundling protein (Fscn1) encode proteins associated with cell morphology and cellular motility. Fscn1 is widely expressed throughout the embryo including in developing somites (De Arcangelis et al., 2004) , and has been implicated in tumor cell migration and invasiveness (Grothey et al., 2000a (Grothey et al., , 2000b . Inhibition of the Fascin-Actin interaction in C2C12 myoblast cells interferes with cell migration and cytoskeletal organization (Adams and Schwartz, 2000) . Similarly, Crk encodes a protein involved in focal adhesion formation and in remodeling of the cytoskeleton at focal adhesions (Feller, 2001) . Knockdown of Crk in NIH-3T3 fibroblasts resulted in decreased PDGF-stimulated migratory ability (Antoku and Mayer, 2009 ). These findings, together with our data, suggest that downregulation of Fscn1 and/or Crk1 in SRF-deficient mid-gestation embryos may significantly contribute to the altered morphology and impaired migratory ability of mesodermal cells in these mutants.
Most of the genes we identified as direct SRF targets in the ps-derived nascent mesoderm are related to cytoskeletal actin reorganization and it was previously shown that genes like Vcl, Cnn2, and others are regulated by SRF in combination with the myocardin-related transcription factors MRTF-A and MRTF-B (Olson and Nordheim, 2010) . The activity of MRTF cofactors, in turn, is controlled by Rho-dependent actin turnover (Miralles et al., 2003) . In the ps of mid-gestational mouse embryos, the disruption of E-cadherin-mediated epithelial cell-cell contacts is indispensable for the ability of cells to undergo EMT and gain motility. Previous reports have demonstrated that the degradation of E-cadherin directly regulates SRF-MRTF activity via the Rho family member RAC1 (Busche et al., 2008) . It is likely that the initial steps in cytoskeletal reorganization required for mesoderm formation during axis elongation utilize SRF in a complex with MRTF cofactors in order to execute the complete program for adopting a migratory capability.
A correlation between impaired mesodermal cell migration and arrested axis elongation has previously been shown in several models. For example, treatment of chick embryos with the cell motility inhibitors Y27632 and blebbistatin causes delayed axis elongation (Bé nazé raf et al., 2010). In migrating cells, the focal adhesion complexes are attached to the ECM, and this attachment requires integrins. There are several studies in mouse embryos showing that interfering with proper expression of either the ECM protein coding gene Fibronectin or members of the Integrin family can cause axis truncations (George et al., 1993; Georges-Labouesse et al., 1996; Yang et al., 1999) . In order to migrate, cells generate a force against the ECM by contracting actin stress fibers that are attached to the focal adhesions (McHardy et al., 2005) . Consequently, impaired function of either Fibronectin or members of the Integrin family affects mesodermal cell migration. In fact, a mutation in the RGD motif of Fibronectin (Fn RGE/RGE ) results in impaired axis elongation, which becomes apparent at E9.0 due to a shift in integrin usage by mesodermal cells at this stage (Giró s et al., 2011 ; T(s)::Cre embryos since, in addition to axis truncation at E8.75-E9.0, both mutants have heart malformations. This suggests that the heart phenotype of Srf flex1/flex1 ; T(s)::Cre embryos may also be partly a result of impaired cell migration and not solely due to the role of SRF in heart differentiation.
The gene Egr1, which is among the best studied SRF targets, was found to be upregulated upon loss of SRF in the caudal region of Srf flex1/flex1 ; T(s)::Cre embryos, suggesting that Egr1 is repressed by SRF in this context. Similar observations were reported by Sullivan and coworkers using a conditional knock-out of Srf in macrophages (Sullivan et al., 2011) . Egr1 is known to be involved in cellular growth control and can control proliferation in hematopoietic stem cells (Min et al., 2008) . Thus, the downregulation of genes involved in cytoskeletal reorganization into a mesenchymal, motile cell type upon loss of Srf, and the simultaneous upregulation of Egr1, might suggest that cell differentiation and cell proliferation also have to be precisely balanced during axis elongation.
It is noteworthy that, since we used T driven expression of Cre to inactivate Srf, Srf should be inactivated in nascent mesoderm beginning with primitive streak formation at around E6.5 however, axis elongation was not visibly affected until E9.0, similar to embryos homozygous for T/T (Yanagisawa et al., 1981) . This indicates a similar change in requirement for Srf and T in early mesoderm formation, as opposed to mesoderm formation at mid-gestation. Several reports have indicated that the latter function of T comprises the maintenance of axial stem cells, though there is not yet direct proof for this proposition (for review see Kondoh and Takemoto, 2012) . Analogous to T, Srf might have an indirect role in the maintenance of axial stem cells by regulating migratory potential. In support of this hypothesis, it has been suggested that loss of B1 Sox gene expression in multipotential paraxial precursor cells causes increased migration into the mesodermal compartment and, thereby, increased production of mesodermal tissue (Yoshida et al., 2014) . Thus, one might argue that the production of mesodermal tissue decreases when migration is impaired; consequently causing axis extension to arrest.
In summary, we show here that during axis elongation a small subset of genes directly depend on SRF and these genes associate primarily with migratory functions in nascent mesodermal cells. This further highlights that, after the initiation of EMT in which E-cadherin is degraded, nascent mesodermal cells have to adopt migratory capabilities in order to properly form the A-P body axis.
4.
Materials and methods
In situ hybridization
Whole mount in situ hybridization was carried out using the standard protocol described on the MAMEP website (http://mamep.molgen.mpg.de). The Srf probe was generated by PCR on cDNA from whole embryos (E9.5) and subcloned into pBluescript II SK(+) (Stratagene) and covers the complete coding region of Srf.
Analysis of gene expression
Quantitative real-time PCR (qPCR): Total RNA was isolated from embryos using the RNeasyMini Kit (Qiagen). Reverse transcription of RNA into cDNA was performed using the SuperScript II First-Strand Synthesis System (Invitrogen). All procedures were performed according to the manufacturer's instructions. Gene expression was analyzed by qPCR using Power SYBR Green PCR Master Mix (Applied Biosystems). The reactions were run in triplicate on a StepOnePlus Real-Time PCR System, and the results were analyzed using the StepOnePlus Software v2.0.2 (Applied Biosystems). ; T(s)::Cre caudal ends at E8.5, 8.75 and 9.0 and those of the appropriate heterozygous littermates were analyzed using Illumina whole-genome expression arrays . For each sample, four biological replicates were compared to four control samples. RNA was isolated from embryonic caudal ends using the RNeasy Mini Kit (Qiagen), and labeled using the Illumina TotalPrep RNA Amplification Kit (Ambion). All procedures were performed according to the manufacturer's instructions. 1 lg of cRNA was hybridized to MouseRef-8 v2.0 Expression BeadChip (Illumina). Arrays were scanned on the Illumina BeadArray Reader and expression data were processed using the lumiR/Bioconductor package (Du et al., 2008) . Raw data were analyzed using background subtraction (bgAdjust) and the quantile normalization method. Differentially expressed genes were identified using the limma1 package. Genes were considered to be significantly dysregulated when they had a fold change Plog 2 0.4 , p 6 0.05. The GEO accession number for the expression data in this paper is GSE44406.
Chromatin immunoprecipitation and massive parallel sequencing
For the SRF-ChIP we used a P19 cell line stably transfected with a plasmid containing a neomycin resistance gene and a CAGGS promoter-driven Srf transgene, coding for a SRF containing an Avi-tag (SLNDIFEAQKIEW) at the C-terminus. The cells were cultivated under standard conditions. At a confluence of 70-80% (approx. 2.5-4 · 10 7 cells on a 10 cm dish), the cells were cross-linked with 0.75% formaldehyde for 10 min at room temperature, followed by a 5 min incubation with glycine (0.125 M). Cells were scraped from the dish, washed three times with PBS and lysed using 400 ll Upstate lysis buffer at 7°C for 30 min in a thermoshaker at 750 rpm. Chromatin was fragmented with a Branson Digital Sonifier II W-450 (3 mm tip) using 6 · 10 s pulses with 50 s breaks and fragmentation was verified on an agarose gel (mean size $300 bp). The sample was centrifuged (10,000 rcf, 1 min, 8°C) and used for ChIP according to the Upstate protocol, using 2 lg of SRF antibody (Santa Cruz; sc-335 X) in a 400 ll total volume. To decrease nonspecific binding of DNA, the washing times were increased from 8 min to 16 min. Massive parallel sequencing was performed by single read analysis with the Illumina Genome Analyzer. Library preparation and sequencing was performed by the Next Generation Sequencing Core Facility at Max-Planck Institute for Molecular Genetics according to the Illumina ChIP-seq standard protocol. Sequences were mapped against the mouse genome using the bowtie software (Langmead et al., 2009 ) and peaks were identified with SICER (Zang et al., 2009 ).
Ex vivo migration assay
To analyze the migratory potential of SRF-deficient mesodermal cells, caudal ends from E9.5 Srf flex1/flex1 ; T(s)::Cre and from control littermate embryos were dissected, split along the midline and plated on l-slides (ibidi; Martinsried). The slides had been coated one day earlier with the extracellular matrix protein Fibronectin (Calbiochem #341631). For this purpose, Fibronectin was diluted (1:100) with PBS, pipetted onto the l-slides, and stored at 4°C. Shortly before usage, the Fibronectin was washed off twice with PBS, and DMEM/10% FBS was added. The embryonic tissue was placed cut side down onto slides and attached within one hour. Next, medium was removed until the tissue was at the air/liquid interface and the explants were cultivated under standard cell culture conditions. Medium was exchanged daily. After two days, the maximal migration distance was measured and explants were processed for immunofluorescence.
For the timelapse analysis the explants were analyzed on a Zeiss LSM710NLO in an incubation chamber under 65% O 2 , 5% CO 2 and 30% N 2 conditions in DMEM F12 media containing 5 mM Glucose, 1 mM Glutamine and 1% BSA (Lauschke et al., 2013) . A z-stack of 5 images with 2 · 2 overlapping tiles was taken every 20 min using the ZEN software (Zeiss). Single projected and stitched images were then used to compile the movie using the ImageJ software.
Immunohistochemistry
Whole embryos were fixed in 4% paraformaldehyde overnight. Following standard ethanol processing they were embedded in paraffin and sectioned at 5 lm. Sections were incubated with anti-Brachyury (1:400, R&D Systems), anti-Ecadherin (1:200, BD Bioscience), anti-Vimentin (1:50, Santa Cruz) and anti-H3S10P (1:500, Millipore) primary antibodies. After counterstaining with secondary Cy3 coupled antibodies (Life Technologies), sections were mounted using VECTA-SHIELD mounting medium with DAPI (Vector Laboratories Inc.).
Explants from the ex vivo assay were stained using Phalloidin-Fluorescein-isothiocyanate (FITC) conjugate (Sigma) according to the manufacturer's instructions at a dilution of 1:50 in PBS. Primary antibodies were used as described above and focal adhesions were visualized using an antibody against Vinculin (Abcam), according to standard procedures at a dilution of 1:100.
For visualization of apoptotic cells, LysoTrackerÒ Red DND-99 (Life Technologies) was used on the explants as described previously (Zucker et al., 1999 ).
4.6.
Flow cytometry analysis of apoptotic cells
Embryo cell suspensions were prepared by incubating head or tail fractions, or single explants in 0.05% Trypsin/ EDTA for 5 min on ice with occasional shaking. Trypsin was quenched by adding 5% BSA/PBS for 5 min and the single suspension washed twice with PBS on ice. The Annexin-V-FLUOS (Roche) staining kit was used according to the manufacturer's protocol. Prior to analysis on a FACS Aria II (BD Biosciences) the suspension was filtered through a 30 lm mesh filter (BD Biosciences). The data were analyzed using the FlowJo software (Treestar).
